Skip to main content
Top
Published in: Nutrition & Metabolism 1/2016

Open Access 01-12-2016 | Erratum

Erratum to: Assessment of Vitamin D status in a group of Egyptian children with non alcoholic fatty liver disease (multicenter study)

Authors: Amal Ahmed Mohamed, Maha Abdel Ghany, Gehan Lotfy Abdel Hakeem, Aya Mostafa, Rania Abdelmonem Khattab, Asmaa Mahmoud Abdalla, Laila El Morsi Abou El Fotoh, Abdel Azeem El Mazary, Madiha Abdalla Sayed, Ashraf Mohamed Abdel Fadil

Published in: Nutrition & Metabolism | Issue 1/2016

Login to get access

Excerpt

After publication of this article [1], the authors noticed errors to the author list, Authors’ Contributions section and the author affiliation for Aya Mostafa. …
Literature
1.
go back to reference Mohamed et al. Assessment of Vitamin D status in a group of Egyptian children with non alcoholic fatty liver disease (multicenter study). Nutrition & Metabolism. 2016;13:53. doi:10.1186/s12986-016-0112-z. Mohamed et al. Assessment of Vitamin D status in a group of Egyptian children with non alcoholic fatty liver disease (multicenter study). Nutrition & Metabolism. 2016;13:53. doi:10.​1186/​s12986-016-0112-z.
Metadata
Title
Erratum to: Assessment of Vitamin D status in a group of Egyptian children with non alcoholic fatty liver disease (multicenter study)
Authors
Amal Ahmed Mohamed
Maha Abdel Ghany
Gehan Lotfy Abdel Hakeem
Aya Mostafa
Rania Abdelmonem Khattab
Asmaa Mahmoud Abdalla
Laila El Morsi Abou El Fotoh
Abdel Azeem El Mazary
Madiha Abdalla Sayed
Ashraf Mohamed Abdel Fadil
Publication date
01-12-2016
Publisher
BioMed Central
Published in
Nutrition & Metabolism / Issue 1/2016
Electronic ISSN: 1743-7075
DOI
https://doi.org/10.1186/s12986-016-0140-8

Other articles of this Issue 1/2016

Nutrition & Metabolism 1/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine